Company Filing History:
Years Active: 1984-1991
Title: Jean Bertin: Innovator in Pharmaceutical Chemistry
Introduction
Jean Bertin is a notable inventor based in Clamart, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating psychotic disorders. With a total of 6 patents to his name, Bertin's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents, Bertin has developed derivatives of (1-hydroxy-2-piperidylalkyl-indol-2-ones and 2-quinolinones. One of his notable inventions is a compound in the form of a pure optical isomer or a mixture thereof, which includes a specific formula involving various chemical groups. Additionally, he has worked on methods for treating psychotic disorders, particularly focusing on Ifenprodil and its analogues, which are useful for treating conditions such as schizophrenia.
Career Highlights
Jean Bertin has had a distinguished career, primarily working with Synthelabo, a company known for its innovative pharmaceutical products. His research and inventions have contributed to advancements in the treatment of mental health disorders, showcasing his commitment to improving patient outcomes.
Collaborations
Bertin has collaborated with several esteemed colleagues, including Jonathan Reid Frost and Alexander E Wick. These partnerships have further enhanced the scope and impact of his research in the pharmaceutical field.
Conclusion
In summary, Jean Bertin is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of psychotic disorders. His contributions continue to influence the medical community and improve the lives of many patients.